StockData
Cellebrite DI Ltd. logo

Cellebrite DI Ltd. (CLBT) stock

CLBTNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 3, 2026Score 13/30
$10.65−0.47 (-4.23%)

Close on Nov 17, 2026Market cap $2.66BP/E 34.4Yield –

Earnings

Cellebrite DI's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$131.10M
+15.7% on a year earlier
Non-GAAP diluted earnings per share, Q2 FY2026
$0.11
$0.12 a year earlier
Latest guidance
Issued
Aug 13, 2026 · 6 items

Quarterly results

Revenue and earnings per share from each of Cellebrite DI's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open$131.10M+15.7%$0.02$0.11Release
Q4 FY2025ended Dec 31, 2025Feb 11, 2026before the open––––Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$113.30M+18.4%$0.08$0.12Release
Q4 FY2024ended Dec 31, 2024Feb 13, 2025before the open$109.00M+17.2%$0.08$0.10Release
Q2 FY2024ended Jun 30, 2024Aug 15, 2024before the open$95.70M+24.8%-$0.12$0.10Release
Q4 FY2023ended Dec 31, 2023Feb 15, 2024before the open$93.00M–-$0.08$0.11Release
Q2 FY2023ended Jun 30, 2023Aug 8, 2023before the open$76.70M–-$0.17$0.05Release
Q4 FY2022ended Dec 31, 2022Feb 15, 2023before the open––––Release
Q2 FY2022ended Jun 30, 2022Aug 11, 2022before the open––––Release
Q4 FY2021ended Dec 31, 2021Feb 16, 2022before the open––––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Cellebrite DI's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueQ3 FY2026$145.00M – $148.00M–NewAug 13, 2026
Adjusted EBITDAnon-GAAPQ3 FY2026$42.00M – $45.00M–NewAug 13, 2026
ARRQ3 FY2026$524.00M – $528.00M–NewAug 13, 2026
RevenueFY2026$555.00M – $561.00M–NewAug 13, 2026
Adjusted EBITDAnon-GAAPFY2026$153.00M – $159.00M–NewAug 13, 2026
ARRFY2026$550.00M – $560.00M–NewAug 13, 2026

Guidance history

Every forecast Cellebrite DI put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 13, 2026Adjusted EBITDAQ3 FY2026$42.00M – $45.00MNew
Aug 13, 2026Adjusted EBITDAFY2026$153.00M – $159.00MNew
Aug 13, 2026ARRFY2026$550.00M – $560.00MNew
Aug 13, 2026ARRQ3 FY2026$524.00M – $528.00MNew
Aug 13, 2026RevenueFY2026$555.00M – $561.00MNew
Aug 13, 2026RevenueQ3 FY2026$145.00M – $148.00MNew
Aug 14, 2025Adjusted EBITDAFY2025$118.00M – $123.00MRaised
Aug 14, 2025Adjusted EBITDAQ3 FY2025$31.00M – $34.00MNew
Aug 14, 2025ARRFY2025$460.00M – $475.00MLowered
Aug 14, 2025ARRQ3 FY2025$435.00M – $445.00MNew
Aug 14, 2025Adjusted EBITDA marginFY202525% – 26%Raised
Aug 14, 2025Adjusted EBITDA marginQ3 FY202526% – 27%New
Aug 14, 2025RevenueQ3 FY2025$121.00M – $126.00MNew
Aug 14, 2025RevenueFY2025$465.00M – $475.00MLowered
Feb 13, 2025Adjusted EBITDAFY2025$113.00M – $123.00MNew
Feb 13, 2025Adjusted EBITDAQ1 FY2025$22.00M – $24.00MNew
Feb 13, 2025Adjusted EBITDA marginQ1 FY202521%New
Feb 13, 2025ARRQ1 FY2025$406.00M – $411.00MNew
Feb 13, 2025Adjusted EBITDA marginFY202524% – 25%New
Feb 13, 2025ARRFY2025$480.00M – $495.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Cellebrite DI filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?